Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:88470656
Filing Date:06/12/2019
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Vapium Inc.
*STREET
661 Unitersity Ave #1300
*CITY
Toronto
*COUNTRY
Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
M5G0B7
EMAIL ADDRESS
michael@vapium.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
LEGAL ENTITY INFORMATION
*TYPE
CORPORATION
* STATE/COUNTRY OF INCORPORATION
Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS
005
*IDENTIFICATION
Medicated confectionery; Medicated moisturizers
*FILING BASIS
SECTION 1(b)
*INTERNATIONAL CLASS
009
*IDENTIFICATION
Electronic storage device in the nature of memory media for storing information collected from medical ventilators
*FILING BASIS
SECTION 1(b)
*INTERNATIONAL CLASS
010
*IDENTIFICATION
Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of sleep depravation, amxiety, pain,
headache, inflamation
*FILING BASIS
SECTION 1(b)
*INTERNATIONAL CLASS
035
*IDENTIFICATION
Providing advertising, marketing and promotional services for the pharmaceutical and medical industry
*FILING BASIS
SECTION 1(b)
*INTERNATIONAL CLASS
042
*IDENTIFICATION
Medical research; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific
research information in the field of pharmaceuticals and clinical trials; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate
health and medical information and reports
*FILING BASIS
SECTION 1(b)
*INTERNATIONAL CLASS
044
*IDENTIFICATION
Medical counseling relating to stress; Medical services; Remote monitoring of data indicative of the health or condition of an individual or
group of individuals for medical diagnosis and treatment purposes
*FILING BASIS
SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
*TRANSLITERATION
(if applicable)
*CLAIMED PRIOR REGISTRATION
(if applicable)
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
CORRESPONDENCE INFORMATION
*NAME
Vapium Inc.
FIRM NAME
Vapium Inc.
*STREET
661 Universiy Ave Suite 1300
*CITY
Toronto
*COUNTRY
Canada
*ZIP/POSTAL CODE
M5G0B7
PHONE
+1-
*EMAIL ADDRESS
michael@vapium.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Plus
NUMBER OF CLASSES
6
FEE PER CLASS
225
*TOTAL FEE PAID
1350
SIGNATURE INFORMATION
* SIGNATURE
/Michael Trzecieski/
* SIGNATORY'S NAME
Michael Trzecieski
* SIGNATORY'S POSITION
CEO
* DATE SIGNED
06/12/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:88470656
Filing Date:06/12/2019
To the Commissioner for Trademarks:
MARK: ACCUDOSE (Standard Characters, see mark)
The mark in your application is ACCUDOSE.
The applicant, Vapium Inc., a corporation of Canada, having an address of
661 Unitersity Ave #1300
Toronto M5G0B7
Canada
michael@vapium.com
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Medicated confectionery; Medicated moisturizers
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 009: Electronic storage device in the nature of memory media for storing information collected from medical ventilators
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 010: Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of sleep depravation, amxiety,
pain, headache, inflamation
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 035: Providing advertising, marketing and promotional services for the pharmaceutical and medical industry
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 042: Medical research; Providing medical and scientific research information in the field of clinical trials; Providing medical and
scientific research information in the field of pharmaceuticals and clinical trials; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and
generate health and medical information and reports
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 044: Medical counseling relating to stress; Medical services; Remote monitoring of data indicative of the health or condition of an
individual or group of individuals for medical diagnosis and treatment purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
The applicant's current Correspondence Information:
Vapium Inc.
Vapium Inc.
661 Universiy Ave Suite 1300
Toronto M5G0B7, Canada
+1-(phone)
michael@vapium.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $1350 has been submitted with the application, representing payment for 6 class(es).
Declaration
Declaration Signature
Signature: /Michael Trzecieski/ Date: 06/12/2019
Signatory's Name: Michael Trzecieski
Signatory's Position: CEO
Payment Sale Number: 88470656
Payment Accounting Date: 06/13/2019
Serial Number: 88470656
Internet Transmission Date: Wed Jun 12 17:28:52 EDT 2019
TEAS Stamp: USPTO/FTK-XX.XXX.XXX.XXX-201906121728527
01157-88470656-620a6e0a81e8f1b66ac8d654d
949ff48e4da08568f23da1fc9ac971f84ce1c292
44-CC-4400-20190612165420879213